Improvements in Lung Function with Nebulized Revefenacin in the Treatment of Patients with Moderate to Very Severe COPD: Results from Two Replicate Phase III Clinical Trials.

导出 LinkOut

翻译打印收藏纠错

作者： Gary T,Ferguson ^[1] ; Gregory,Feldman ^[2] ; Krishna K,Pudi ^[3] ; Chris N,Barnes ^[4] ; Edmund J,Moran ^[4] ; Brett,Haumann ^[4] ; Srikanth,Pendyala ^[4] ; Glenn,Crater ^[4]

作者单位： Pulmonary Research Institute of Southeast Michigan, Farmington Hills. ^[1] South Carolina Pharmaceutical Research, Spartanburg. ^[2] Sherman Clinical Research, Sherman, Texas. ^[3] Theravance Biopharma US, Inc., South San Francisco, California. ^[4]

关键词 FEV1 Phase III randomized controlled trial Revefenacin chronic obstructive pulmonary disease copd forced expiratory volume in 1 second nebulized therapy,Phase III randomized controlled trial

DOI 10.15326/jcopdf.6.2.2018.0152

PMID 30974049

发布时间 2022-04-08

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览10

Chronic obstructive pulmonary diseases (Miami, Fla.)

2019年6卷2期

154-165页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Improvements in Lung Function with Nebulized Revefenacin in the Treatment of Patients with Moderate to Very Severe COPD: Results from Two Replicate Phase III Clinical Trials.

Chronic obstructive pulmonary diseases (Miami, Fla.)

相似文献

Chronic obstructive pulmonary diseases (Miami, Fla.)

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Improvements in Lung Function with Nebulized Revefenacin in the Treatment of Patients with Moderate to Very Severe COPD: Results from Two Replicate Phase III Clinical Trials.

Chronic obstructive pulmonary diseases (Miami, Fla.)

相似文献

Chronic obstructive pulmonary diseases (Miami, Fla.)

相关期刊

检索历史清除